http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GR-1009516-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e3f12feb7450af344603eb6a4d50af1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_99a5693fc13a0f4106a3470a73967bd6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9a2b6807467efc647a54493bf9a139cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aba8e323d35f5406a3d8c5fb17e82d84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d8bdf1bd08e529f06d1c2772c738c8a1
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0453
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F13-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K103-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2018-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_283e63d4f4d59c002a429e25f370d920
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f142f04f7c51d634d1fe6b2ddb8ee20d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0dd8bc85e087cb5392c362d6c9088cb6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16bec16a83b91da8aff677878c0dcbdb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef7fb420007a7fe92b342fca16a49a45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7c76c45dcb461fcc8aade23749cacfd
publicationDate 2019-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GR-1009516-B
titleOfInvention Tricarbonyl-METAL COMPLEXES WITH METAPTOSEOS benzoheterocyclic derivative of the cyclopentadienyl ANIONTOS WITH HIGH PERMEABILITY the BBB FOR APPLICATIONS IN DIAGNOSIS AND TREATMENT OF DISEASES OF CNS
abstract The present invention relates to complex metal transition compounds, with an emphasis on 99mTc and Re, which exhibit high blood-brain barrier permeability so that they can be used as diagnostic / therapeutic agents for CNS diseases. The compounds are of the general formula wherein the M (CO) 3+ tricarbonyl metal nucleus is complexed with a cyclopentadienyl anion attached to heterocyclic compounds of the benzothiazole, benzimidazole and benzoxazole families. The crossing of the blood-brain barrier for three compounds with M = 99mTc is between 7.04 and 3.99% ID / gr in 2 min. In addition, the compounds bind in vitro to β-amyloid peptide fibrils and to amyloid plaques characterizing Alzheimer's disease, inhibit β-amyloid peptide toxicity in cell cultures, and produce ROS associated with Alzheimer's disease. They therefore have proven potential for application in the preparation of diagnostic / therapeutic preparations for Alzheimer's disease. In addition, the high crossing of the blood-brain barrier makes them candidates for investigation for the preparation of drugs for CNS diseases.
priorityDate 2018-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409451045
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9228
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407625565
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9548686
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486558

Total number of triples: 35.